The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Incidence and natural history of bone metastases in neuroendocrine tumors.
Jennifer Keiser
No relevant relationships to disclose
Eric K. Nakakura
No relevant relationships to disclose
Laurel Imhoff
No relevant relationships to disclose
Margaret A. Mayorga
No relevant relationships to disclose
Sarah Bobiak
No relevant relationships to disclose
Alan Paul Venook
Consultant or Advisory Role - Genentech (U); Novartis (U)
Research Funding - Novartis; Roche/Genentech
Emily K. Bergsland
Consultant or Advisory Role - Novartis (U); Pfizer (U)
Research Funding - Genentech/OSI; Novartis